Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Rebecca Berdeaux, PhD (she/her/hers)

CellChorus, Inc., Texas, United States

Rebecca Berdeaux, Ph.D., is Vice President of Science at CellChorus, the leader in dynamic single cell analysis. Using her expertise in dynamic cellular signaling and leadership of scientific teams, she is overseeing development of the CellChorus TIMING™ platform for single-cell analysis assays for immunooncology and other areas of the life sciences. Dr. Berdeaux earned a B.S. in Biology from the University of Illinois Urbana-Champaign and a Ph.D. in Molecular and Cell Biology from University of California, Berkeley. Following postdoctoral work at the Salk Institute, she took a faculty position in the Integrative Biology and Pharmacology department at McGovern Medical School, University of Texas-Health in Houston, TX. Dr. Berdeaux’s academic research has explored molecular signaling mechanisms regulating cancer cell invasion and metastasis, gene expression, stem cell proliferation, and metabolism in exercise, type 2 diabetes, and muscle regeneration. Her lab created several transgenic mouse models, including mice for tissue-specific chemical-genetic activation of cAMP signaling, which have been shared internationally as a resource. She has been a reviewer for several NIH study sections and private foundation grant review panels, served as Chairperson of the 2022 Gordon Research Conference on Protein Phosphorylation and G-Protein Mediated Signaling, and received numerous awards for teaching and mentoring. Dr. Berdeaux is passionate about mentoring developing investigators and helping provide tools that enable scientists to address mechanistic questions to bring precision therapy to more patients.

Disclosure information not submitted.

Presentation(s):